☆ 4.7 Letter

Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia

LEUKEMIA (2013)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 27, Issue 8, Pages 1769-1773

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2013.37

Keywords

-

Categories

Oncology Hematology

Funding

  1. Intramural NIH HHS [ZIA HL002346-09] Funding Source: Medline
  2. NCI NIH HHS [P50 CA13080503] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.